 Dr. Rebeck, I did want to raise this issue because there are some forms of cancer that in the recent past we've seen recommendations for screening change to have the years be further apart, for example. Prostate cancer is a good example. What do you think of Dr. Esserman's idea that some of what we're seeing may be because we're calling things cancer at an earlier stage that, as she says, may not necessarily end up being truly malignant?